Administering immunotherapy when the tumor microenvironment is most susceptible to T cells enhances treatment efficacy in ...

Immune checkpoint inhibitors (ICIs) redefined the therapeutics of non-small cell lung cancer (NSCLC), leading to significant survival benefits and unprecedented durable responses. However, the ...

Scientists collaborate to enhance advanced microscopy techniques with AI, aiming to improve the understanding of glioblastoma brain tumors. Imagine building a traffic surveillance camera that could de ...

There is a challenge related to prostate and many other cancers that cancer cells form resistance to treatments as the disease progresses. However, these resistance mechanisms are not yet fully ...

Treatment-resistant cells are a challenge related to prostate cancer and many other cancers, which arises as the disease ...

In a study published in Advanced Functional Materials, a research team from the Shanghai Institute of Materia Medica (SIMM) ...

There is a challenge related to prostate and many other cancers that cancer cells form resistance to treatments as the disease progresses. However ...

Certain types of tumors make up the majority of that 20%, such as melanoma, non-small cell lung cancer, and certain ...

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients ...

For more information, please refer to the full article in JAMA Oncology.